Outcome of COVID-19 and tolerance of Remdesivir in patients with renal failure: a single center experience from Pakistan.

Zaheer Udin Babar,Sunil Kumar Dodani,Asma Nasim,Jawahar Lal Langhani, Sanjay Kumar Badlani

Journal of infection in developing countries（2023）

引用 0|浏览0

暂无评分

摘要

COVID-19 in renal failure has a high risk for ICU admissions leading to increased mortality. Multiple comorbidities and raised inflammatory markers are predictors of poor outcomes. We observed no significant drug-related adverse effects, and none of our patients required discontinuation of RDV due to worsening renal function.

查看译文

关键词

COVID-19, renal failure, remdesivir, mortality

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要